Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial

Author:

Camaro Cyril1ORCID,Aarts Goaris W A1ORCID,Adang Eddy M M2ORCID,van Hout Roger3ORCID,Brok Gijs3,Hoare Anouk4,Rodwell Laura2ORCID,de Pooter Frank4,de Wit Walter4,Cramer Gilbert E1ORCID,van Kimmenade Roland R J1ORCID,Damman Peter1ORCID,Ouwendijk Eva5ORCID,Rutten Martijn6,Zegers Erwin7,van Geuns Robert-Jan M1ORCID,Gomes Marc E R7,van Royen Niels1ORCID

Affiliation:

1. Department of Cardiology, Radboud University Medical Centre , P.O. Box 9101, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, Gelderland , The Netherlands

2. Department of Health Evidence, Radboud Institute for Health Sciences , Geert Grooteplein 21, 6525 EZ Nijmegen, Gelderland , The Netherlands

3. Ambulance Service, Safety region Gelderland-Zuid , Professor Bellefroidstraat 11, 6525 AG Nijmegen, Gelderland , The Netherlands

4. Ambulance Service, Witte Kruis , Ringveste 7A, 3992 DD Houten, Utrecht , The Netherlands

5. General Practitioner Centre Nijmegen and Boxmeer , Weg door Jonkerbos 108, 6532 SZ Nijmegen, Gelderland , The Netherlands

6. Scientific Centre for Quality of Healthcare (IQ Healthcare), Radboud University Medical Centre , Kapittelweg 54, 6525 EP Nijmegen, Gelderland , The Netherlands

7. Department of Cardiology, Canisius Wilhelmina Hospital , Weg door Jonkerbos 100, 6532 SZ Nijmegen, Gelderland , The Netherlands

Abstract

Abstract Aims Patients with suspected non-ST-segment elevation acute coronary syndrome (NSTE-ACS) are routinely transferred to the emergency department (ED). A clinical risk score with point-of-care (POC) troponin measurement might enable ambulance paramedics to identify low-risk patients in whom ED evaluation is unnecessary. The aim was to assess safety and healthcare costs of a pre-hospital rule-out strategy using a POC troponin measurement in low-risk suspected NSTE-ACS patients. Methods and results This investigator-initiated, randomized clinical trial was conducted in five ambulance regions in the Netherlands. Suspected NSTE-ACS patients with HEAR (History, ECG, Age, Risk factors) score ≤3 were randomized to pre-hospital rule-out with POC troponin measurement or direct transfer to the ED. The sample size calculation was based on the primary outcome of 30-day healthcare costs. Secondary outcome was safety, defined as 30-day major adverse cardiac events (MACE), consisting of ACS, unplanned revascularization or all-cause death. : A total of 863 participants were randomized. Healthcare costs were significantly lower in the pre-hospital strategy (€1349 ± €2051 vs. €1960 ± €1808) with a mean difference of €611 [95% confidence interval (CI): 353–869; P < 0.001]. In the total population, MACE were comparable between groups [3.9% (17/434) in pre-hospital strategy vs. 3.7% (16/429) in ED strategy; P = 0.89]. In the ruled-out ACS population, MACE were very low [0.5% (2/419) vs. 1.0% (4/417)], with a risk difference of −0.5% (95% CI −1.6%–0.7%; P = 0.41) in favour of the pre-hospital strategy. Conclusion Pre-hospital rule-out of ACS with a POC troponin measurement in low-risk patients significantly reduces healthcare costs while incidence of MACE was low in both strategies. Trial registration Clinicaltrials.gov identifier NCT05466591 and International Clinical Trials Registry Platform id NTR 7346.

Funder

Netherlands Organisation for Health Research and Development

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3